Division of the N2 Stage According to the Multiplicity of the Involved Nodal Stations May be Necessary in the N2-NSCLC Patients Who are Treated with Postoperative Radiotherapy |
Yoon, Hong-In
(Departments of Radiation Oncology, Yonsei University College of Medicine, Yonsei University Health System)
Kim, Yong-Bae (Departments of Radiation Oncology, Yonsei University College of Medicine, Yonsei University Health System) Lee, Chang-Geol (Departments of Radiation Oncology, Yonsei University College of Medicine, Yonsei University Health System) Lee, Ik-Jae (Departments of Radiation Oncology, Yonsei University College of Medicine, Yonsei University Health System) Kim, Song-Yih (Departments of Radiation Oncology, Yonsei University College of Medicine, Yonsei University Health System) Kim, Jun-Won (Departments of Radiation Oncology, Yonsei University College of Medicine, Yonsei University Health System) Kim, Joo-Hang (Departments of Medical Oncology, Yonsei University College of Medicine, Yonsei University Health System) Cho, Byung-Chul (Departments of Medical Oncology, Yonsei University College of Medicine, Yonsei University Health System) Lee, Jin-Gu (Departments of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Yonsei University Health System) Chung, Kyung-Young (Departments of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Yonsei University Health System) |
1 | Keller SM, Adak S, Wagner H, et al. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer: Eastern Cooperative Oncology Group. Ann Thorac Surg 2000;70:358-365 DOI PUBMED ScienceOn |
2 | Andre F, Grunenwald D, Pignon JP, et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 2000;18:2981-2989 PUBMED |
3 | Osaki T, Nagashima A, Yoshimatsu T, et al. Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer. Lung Cancer 2004;43:151-157 DOI ScienceOn |
4 | Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-1717 DOI PUBMED ScienceOn |
5 | Watanabe Y, Hayashi Y, Shimizu J, et al. Mediastinal nodal involvement and the prognosis of non-small cell lung cancer. Chest 1991;100:422-428 DOI ScienceOn |
6 | Martini N, Flehinger BJ. The role of surgery in N2 lung cancer. Surg Clin North Am 1987;67:1037-1049 PUBMED |
7 | Naruke T, Goya T, Tsuchiya R, et al. The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis. Ann Thorac Surg 1988;46:603-610 DOI PUBMED ScienceOn |
8 | Douillard JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 2006;7:719-727 DOI ScienceOn |
9 | Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005;352:2589-2597 DOI ScienceOn |
10 | Inoue M, Sawabata N, Takeda S, et al. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe. J Thorac Cardiovasc Surg 2004;127:1100-1106 DOI ScienceOn |
11 | Ichinose Y, Kato H, Koike T, et al. Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. J Thorac Cardiovasc Surg 2001;122:803-808 DOI ScienceOn |
12 | Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997;111:1718-1723 DOI ScienceOn |
13 | Debevec M, Bitenc M, Vidmar S, et al. Postoperative radiotherapy for radically resected N2 non-small-cell lung cancer (NSCLC): randomised clinical study 1988-1992. Lung Cancer 1996;14:99-107 DOI ScienceOn |
14 | Lee JG, Lee CY, Park IK, et al. The prognostic significance of multiple station N2 in patients with surgically resected stage IIIA N2 non-small cell lung cancer. J Korean Med Sci 2008;23:604-608 DOI ScienceOn |
15 | Vansteenkiste JF, De Leyn PR, Deneffe GJ, et al. Clinical prognostic factors in surgically treated stage IIIA-N2 non-small cell lung cancer: analysis of the literature. Lung Cancer 1998;19:3-13 DOI ScienceOn |
16 | Grunenwald D, Le Chevalier T. Re: stage IIIA category of non-small-cell lung cancer: a new proposal. J Natl Cancer Inst 1997;89:88-89 DOI ScienceOn |
17 | Lee CG, Kim GE, Suh CO, et al. Postoperative radiation therapy in resected stage II and IIIA non-small cell lung cancer(Yonsei Cancer Center 20-year experience). Korean J Thoracic Cardiovas Surg 1993;26:686-695 |
18 | The Lung Cancer Study Group. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N Engl J Med 1986;315:1377-1381 DOI PUBMED ScienceOn |
19 | Park CI, Kim JH, Kim JH. Postoperative radiation therapy in non-small-cell lung cancer. J Korean Soc Ther Radiol Oncol 1988;6:195-202 |
20 | Rusch VW, Crowley J, Giroux DJ, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2007;2:603-612 DOI ScienceOn |
21 | Ruckdeschel JC. Combined modality therapy of non-small cell lung cancer. Semin Oncol 1997;24:429-439 PUBMED |
22 | Pearson FG, DeLarue NC, Ilves R, et al. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardiovasc Surg 1982;83:1-11 PUBMED |
23 | Lally BE, Zelterman D, Colasanto JM, et al. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol 2006;24:2998-3006 DOI ScienceOn |
24 | Mountain CF. Surgery for stage IIIa-N2 non-small cell lung cancer. Cancer 1994;73:2589-2598 DOI PUBMED ScienceOn |
25 | Naruke T, Tsuchiya R, Kondo H, et al. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. Ann Thorac Surg 2001;71:1759-1764 DOI ScienceOn |